Skip to main content

Month: March 2021

Allied Corp Secures US Footprint in Preparation for US Federal Legalization of Cannabis With Signing of Land Lease, Purchase of US License and Master Service Agreement

KELOWNA, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is an international medical company focused on creating and providing health solutions to address today’s medical mental health issues. This press releases comes as a follow up to the February 17th 2021 press release announcing the letter of intent (LOI) to sign a land lease and purchase of a US-registered cultivation license. Allied’s wholly owned subsidiary Tactical Relief, LLC has signed a 25-year land lease in the Las Vegas area. This land has ample space to install Allied’s building and further space for future expansion. Allied has completed the construction of an approximate $3.5 million, 9,000 square foot, GMP-complaint facility that is ready to be deployed from the Las Vegas construction factory...

Continue reading

Vertex Introduces Indirect Tax Accelerator for Oracle Fusion Cloud ERP

KING OF PRUSSIA, Pa., March 31, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions and a member of Oracle PartnerNetwork (OPN), is introducing the Vertex® Indirect Tax Accelerator for Oracle Fusion Cloud Enterprise Resource Planning (ERP). This solution is hosted on Oracle Cloud Infrastructure (OCI) to support advanced tax management worldwide. As more companies move technology applications to the cloud, Vertex continues to provide integrated SaaS offerings to manage tax and accelerate global growth.  The Vertex Accelerator streamlines previously manual tasks and gives customers faster, more detailed adjustments to tax configurations and data to help businesses as they make acquisitions, introduce new products, and expand into new regions. The Vertex Accelerator...

Continue reading

Tuscan Holdings Corp. Announces Annual Meeting of Stockholders to be Held April 28, 2021, to Approve Extension Amendment, among other things

Proxy Materials Mailed to Stockholders of Record as of Close of Business on March 17, 2021NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) — Tuscan Holdings Corp. (Nasdaq: THCB) (“Tuscan”) today announced that it has mailed proxy materials for the Annual Meeting of the Company’s stockholders to be held on April 28, 2021.  The proxy materials have been mailed to all holders of record as of the close of business on the record date which was set for March 17, 2021. In addition to the election of one Class I director, Tuscan is asking stockholders to approve an extension proposal that will allow the Company more time to complete its previously announced business combination with Microvast, Inc. (“Microvast”). “Tuscan has filed the preliminary proxy statement for its business combination with Microvast,  but...

Continue reading

Meritage Homes Announces Offering of $400 Million of Senior Unsecured Notes Due 2029

SCOTTSDALE, Ariz., March 31, 2021 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of senior unsecured notes due 2029 (the “notes”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act. Meritage intends to use a portion of the proceeds to redeem all of its $300 million aggregate principal amount of 7.00% senior notes due 2022 (“existing notes”). Final terms of the notes, including the interest rate, maturity date and other terms, will be determined through negotiations between Meritage...

Continue reading

Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments

Closed $33.6 million PIPE in conjunction with the completion of reverse merger with Proteostasis Therapeutics; commenced trading on the Nasdaq Capital Market under the ticker symbol “YMTX” Initiated dosing in the Phase 1b part of our MAD trial of YMTX-7739 in patients with Parkinson’s Disease; preliminary results expected by mid-year 2021 BOSTON, March 31, 2021 (GLOBE NEWSWIRE) — Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced financial results for the full year ended December 31, 2020 and provided an overview of the Company’s recent corporate developments and upcoming milestones. “Yumanity made important scientific and operational progress throughout the course of the...

Continue reading

DSS Releases Full Year 2020 Financial Results: Income From Continuing Operations Increased $5.7 Million in 2020

Generated positive income of $3.1M vs. a loss of $2.6M in 2019Revenue up 12% to $17.4M in 2020Stockholders’ Equity up 522% to $76.5M ROCHESTER, N.Y., March 31, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in direct marketing, consumer packaging, brand protection technology, healthcare, real estate, blockchain security, and securitized digital assets, today announced its financial results for its fiscal year ended December 31, 2020. “I am pleased to report we made tremendous progress in 2020 toward our goal of transforming DSS, an initiative we first embarked upon in 2019,” stated Frank D. Heuszel, CEO of DSS. “Despite an extremely challenging business environment from COVID-19, our team executed on multiple fronts, generating...

Continue reading

Agreement of shareholders with substantial shareholding

The City of Tallinn and OÜ Utilitas as the shareholders of AS Tallinna Vesi entered into an agreement on 03/02/2021 (hereinafter the Shareholders Agreement) which took effect on 31/03/2021. AS Tallinna Vesi joined the Shareholders Agreement when it came into effect. Pursuant to the clause 7.8 of “Requirements for Issuers” of the market regulation of Nasdaq Tallinn, an Issuer is required to ensure that shareholders holding five per cent (5%) and more of the votes represented by the shares of the Issuer disclose information, through the Issuer, on all the significant provisions of all the agreements made with other shareholders or third parties which are aimed at restricting the free transferability of the shares or which may have a significant effect on the price of the shares. Pursuant to the clause 7.9.3 of “Requirements for Issuers”,...

Continue reading

Olulise osalusega aktsionäride leping

31.03.2021 jõustus Tallinna linna ja OÜ Utilitas vahel 03.02.2021 sõlmitud AS Tallinna Vesi aktsionäride leping (edaspidi Aktsionäride Leping). Jõustumisel liitus Aktsionäride Lepinguga AS Tallinna Vesi. Vastavalt Nasdaq Tallinna börsi reeglite „Nõuded emitentidele“ punktile 7.8 on Emitent kohustatud tagama, et aktsionärid, kes omavad rohkem kui viis protsenti (5%) Emitendi aktsiatega esindatud häältest, avalikustavad Emitendi vahendusel kõigi selliste lepingute olulised tingimused, mis on sõlmitud teise aktsionäri või kolmandate isikutega ning on suunatud aktsiate vaba võõrandamise õiguse piiramisele või mis võivad oluliselt mõjutada aktsiate hinda. Vastavalt „Nõuded emitentidele“ punktile 7.9.3 on Emitent kohustatud viivitamatult avalikustama teabe tehingutest seotud isikutega. Avalikustatav börsiteade selliste tehingute kohta peab...

Continue reading

Odyssey Marine Exploration Reports Full Year 2020 Results and Updates Current Projects

TAMPA, Fla., March 31, 2021 (GLOBE NEWSWIRE) — Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a deep-ocean exploration pioneer engaged in the discovery, validation and development of subsea minerals deposits in an environmentally responsible manner, reported results for the full year ended December 31, 2020, and provided an update on current projects and future plans. “While 2020 was challenging for companies around the globe due to the COVID-19 pandemic, the Odyssey team was able to achieve, and in some cases surpass, the aggressive goals we set for ourselves,” reported Mark D. Gordon, Odyssey Chairman and CEO. “Odyssey’s business is focused on building a portfolio of subsea mineral assets that hold the potential to produce meaningful societal and economic impacts for host countries and tremendous asymmetric returns for investors. “A...

Continue reading

Galectin Therapeutics Reports Fiscal 2020 Financial Results and Provides Business Update

NORCROSS, Ga., March 31, 2021 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2020. These results are included in the Company’s Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said, “I am very encouraged by the progress achieved in fiscal 2020, and remain extremely optimistic for 2021. Given the current challenging environment, I am proud of our success, highlighted by site activations and ongoing enrollment of our innovative NAVIGATE study. This global program continues to be the only active...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.